A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and ...

The inhalers people depend on to breathe are also warming the planet, producing annual emissions equivalent to more than half ...

International asthma guidelines increasingly support the use of inhaled corticosteroid plus fast-acting β-agonist ...

In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children ...

As with other drugs, Tarpeyo (budesonide) can cause side effects, such as swelling of the hands, legs, ankles, or feet and high blood pressure. If these side effects become difficult to tolerate, talk ...

President Donald J. Trump announced an agreement with Pfizer to sell its drug products to Medicaid for much lower prices, ...

AstraZeneca is the latest big pharma group to open up a Direct-To-Consumer (DTC) sales channel in the US, offering three of ...

Changxi Pharma & Huadong Medicine enter commercialization collaboration on the improved respiratory system drug CXG87: Hangzhou, China Friday, October 10, 2025, 11:00 Hrs [IST] Ha ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...